1,631
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Human factors engineering and design validation for the redesigned follitropin alfa pen injection device

, PhD HCLD (AAB), , CPT, , SM MBA, , PhD &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (9)

Andreas Schneider, Reto Jost, Christoph Jordi & Jakob Lange. (2023) Autoinjectors for large-volume subcutaneous drug delivery: a review of current research and future directions. Expert Opinion on Drug Delivery 20:6, pages 815-830.
Read now
Andreas Schneider, Philipp Richard, Philippe Mueller, Christoph Jordi, Mary Yovanoff & Jakob Lange. (2021) User-Centric Approach to Specifying Technical Attributes of Drug Delivery Devices: Empirical Study of Autoinjector-Cap Removal Forces. Patient Preference and Adherence 15, pages 159-168.
Read now
Helen Saunders, Linda Bjärgestad Lamp, Hasan Donat, Monja Messner, Maren Reder & Helen Kendrew. (2021) Risk of dosing errors in ART treatment: user experience of single- vs multi-use follitropin alfa pens. Expert Opinion on Drug Delivery 18:5, pages 643-654.
Read now
Salvatore Longobardi, Anke Seidler, Julian Martins, Francois Beckers, William MacGillivray & Thomas D’Hooghe. (2019) An evaluation of the use and handling errors of currently available recombinant human follicle-stimulating hormone pen injectors by women with infertility and fertility nurses. Expert Opinion on Drug Delivery 16:9, pages 1003-1014.
Read now
Andreas E. Schneider & Jakob Lange. (2018) Pen devices for self-injection: contrasting measured injection force with users’ perceived ease of injection. Expert Opinion on Drug Delivery 15:2, pages 115-125.
Read now
Mary Mahony, Andrea Dwyer, Raschelle Barkume, Allison Strochlic, Fabien Jeannerot & Thomas Stüdeli. (2018) US human factors engineering evaluation of an updated follitropin alfa pen injector (GONAL-f® RFF Redi-ject®) and instructions for use. Expert Opinion on Drug Delivery 15:1, pages 5-15.
Read now
Joan Schertz & Hilary Worton. (2017) Patient evaluation of the redesigned follitropin alfa pen injector. Expert Opinion on Drug Delivery 14:4, pages 473-481.
Read now
Fabien Jeannerot, Alexandra Cusin & Joan Schertz. (2016) Dose accuracy of the redesigned follitropin alfa pen injector for infertility treatment. Expert Opinion on Drug Delivery 13:12, pages 1661-1669.
Read now
Fabien Jeannerot, Thomas Stüdeli, Lisa Gunther-LaVergne, David Hirning & Joan Schertz. (2016) Usability engineering study in the European Union of a redesigned follitropin alfa pen injector for infertility treatment. Expert Opinion on Drug Delivery 13:9, pages 1221-1229.
Read now

Articles from other publishers (4)

Bum Chae Choi, Canquan Zhou, Hong Ye, Yun Sun, Ying Zhong, Fei Gong, Ivan Sini, Nadezda Abramova, Salvatore Longobardi, Miranda Hickey & Thomas D’Hooghe. (2022) A comparative, observational study evaluating dosing characteristics and ovarian response using the recombinant human follicle-stimulating hormone pen injector with small-dose dial in assisted reproductive technologies treatment in Asia: IMPROVE study. Reproductive Biology and Endocrinology 20:1.
Crossref
Teodora Miclăuş, Vasiliki Valla, Angeliki Koukoura, Anne Ahlmann Nielsen, Benedicte Dahlerup, Georgios-Ioannis Tsianos & Efstathios Vassiliadis. (2019) Impact of Design on Medical Device Safety. Therapeutic Innovation & Regulatory Science 54:4, pages 839-849.
Crossref
Katia M. Rojas, Leon Cosler & Daryl L. Santos. (2019) A Narrative Review of FDA Human Factors Validation Requirement: The Needs of Key Stakeholders and Proposal of an Industry (Human Factors Service Providers) Maturity Assessment Tool. Proceedings of the International Symposium on Human Factors and Ergonomics in Health Care 8:1, pages 222-233.
Crossref
Thomas Weinhold, Marzia Del Zotto, Jessica Rochat, Jessica Schiro, Sylvia Pelayo & Romaric Marcilly. (2018) Improving the safety of disposable auto-injection devices: a systematic review of use errors. AAPS Open 4:1.
Crossref